Objective: To assess the efficacy, safety and tolerability of moxifloxacin, an 8-methoxy fluoroquinolone, in patients with respiratory tract infections (RTIs) treated in general practice in Germany.

Moxifloxacin is a good alternative regimen for acute PID but it is costly, and its use should be restricted to areas were gonococcal PID is uncommon. Gonococcal culture and sensitivity testing is ...

A recent study evaluated the preferences of children in three countries for new, more palatable flavour formulations of the antituberculosis drug moxifloxacin. Ed Holt reports. New formulations of the ...